Author:
Ohguri Takayuki,Tani Subaru,Kawarada Yo,Kitahara Masahiro
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION- 2): a randomised, double-blind, placebo-controlled, phase 3 trial;Kang YK;Lancet,2017
2. Immunogenic effect of hyperthermia on enhancing radiotherapeutic efficacy;Lee S;Int J Mol Sci,2018
3. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma;Ito A;Cancer Immunol Immunother,2004
4. Radiotherapy and immunotherapy for cancer: from "systemic" to "multisite";Arina A;Clin Cancer Res,2020
5. Combination of immunotherapy and hyperthermia [Article in Japanese];Kubota Y;Gan To Kagaku Ryoho,2019